• column
  • column
    • Home
    • About Us
      • Our vision
      • Our team
      • Our founders
      • Scientific Advisory Board
      • News & Resources
      • Case Studies
      • Clients
  • column
    • Our Services
      • How we work
      • Project partners
    • Preclinical Research Services
    • Clinical Trial Volunteer Opportunities
    • Clinical Trials Services
  • column
    • Contact
      • Companies
      • Volunteers
    • FOLLOW US
      • X
      • Linkedin
      • Facebook
Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

by Virtus | Nov 3, 2019

Click the button below to read more about this. CLICK HERE FOR...
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Role of deficient type III interferon-lambda production in asthma exacerbations.

Role of deficient type III interferon-lambda production in asthma exacerbations.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Next Entries »

Recent Posts

  • Respiratory Biomarkers: Their Role in Drug Development and Preclinical Research
  • Translational Respiratory Research: Bridging Preclinical Studies and Clinical Success
  • Respiratory Drug Discovery: The First Step Towards Developing New Respiratory Therapies
  • COPD Drug Development: Advancing New Therapies for Chronic Obstructive Pulmonary Disease
  • Asthma Drug Development: Advancing New Treatments for Respiratory Disease

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact